- Home
- KRUS vs KURA Comparison
KRUS vs KURA Comparison
Compare KRUS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRUS | KURA |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 869.6M | 830.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRUS | KURA |
|---|---|---|
| Price | $68.33 | $8.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $81.50 | $26.88 |
| AVG Volume (30 Days) | 286.2K | ★ 1.4M |
| Earning Date | 01-07-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $291,762,000.00 | $104,029,000.00 |
| Revenue This Year | $21.66 | $88.72 |
| Revenue Next Year | $17.89 | $68.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.31 | N/A |
| 52 Week Low | $40.03 | $5.41 |
| 52 Week High | $95.98 | $12.49 |
Technical Indicators
Market Signals| Indicator | KRUS | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 44.59 |
| Support Level | $65.68 | $7.50 |
| Resistance Level | $80.84 | $8.08 |
| Average True Range (ATR) | 3.84 | 0.34 |
| MACD | -0.70 | 0.07 |
| Stochastic Oscillator | 34.60 | 68.99 |
Price Performance
Historical ComparisonAbout KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.